AlphAIalphai — Financial news for AI agents
Stock TitanMAR 311 min read$YDES

YD Bio (YDES) director files Form 3 with no share activity

YD Bio Ltd director Lee Jerry Yin-Chia has filed a Form 3 insider report for YDES, indicating no reported purchases, sales, or other insider transactions. The filing lists him as a director, with all transaction counts and share totals recorded as zero. This Form 3 filing confirms no insider trading activity from the specified director.

Original reporting
Stock Titan
Published Mar 31, 2026, 5:40 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 31, 2026, 6:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$YDES
Neutral
high confidence
Mentioned
$YDES
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$YDESNeutralLow
01

Why it matters

The filing indicates no recent insider trading activity, suggesting no immediate insider-driven market movements.

02

Market read

The news has limited relevance to the broader market; it primarily informs about insider activity levels for YD Bio Ltd.

03

What to watch

Insider activity is just one of many indicators; absence of transactions does not necessarily imply company stability or future performance.

Timing: low

Background

This news pertains to insider reporting requirements, which are routine disclosures for publicly traded companies.

Company-level read

Ticker impact

$YDESNeutralHigh confidence
Context

The news pertains directly to YD Bio Ltd (YDES), specifically regarding insider activity.

Expected impact

Minimal to no immediate price movement expected due to lack of insider activity; however, traders should monitor for future filings.

Evidence & confidence

Form 3 filings are standard disclosures that confirm insider activity levels. The absence of transactions indicates no insider-driven trading signals at this time.

Market effects

Sector

No significant sector-wide implications as insider activity remains unchanged.

Regional

Limited regional impact due to the company's localized insider activity.

Global

Negligible; the news pertains to a specific company's insider filing with minimal broader market influence.

Counterpoint

What could challenge this read

Some traders might interpret the lack of insider activity as a sign of stability or potential complacency, which could be viewed positively or negatively depending on broader market context.

Key entities

  • Company
    YD Bio Ltd

    A biotechnology company listed under ticker YDES.

  • Director
    Lee Jerry Yin-Chia

    Director of YD Bio Ltd who filed the Form 3.

Read at source← All news

Related articles

AUG 8
$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).

fool.com6 min
AUG 8
$BWAMed

Why Is BorgWarner (BWA) Expanding Its Edge In China And EV Systems?

BorgWarner (NYSE:BWA) said it won new variable cam timing system contracts in Europe and China, including a conquest award, and that the wins expand positions with existing customers and replace a competitor on a China program. It also received awards for high voltage inverters and integrated drive modules for hybrid and EV platforms, which it said add to backlog.

simplywall.st4 min